Yüklüyor......
Therapeutically-induced stable disease in oncology early clinical trials
RATIONALE: The RECIST guideline defines four categories of response to treatment for cancer patients according to post-baseline changes in tumor burden, hence ignoring disease history. However, if left untreated, tumors grow exponentially, implying that pretreatment changes in tumor size are key to...
Kaydedildi:
| Yayımlandı: | PLoS One |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Public Library of Science
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7259628/ https://ncbi.nlm.nih.gov/pubmed/32470048 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0233882 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|